Literature DB >> 14973384

The preneoplastic phenotype in murine mammary tumorigenesis.

D Medina1.   

Abstract

Preneoplastic lesions in murine mammary tumorigenesis have been extensively investigated over the past 50 years. The two general types of lesion that have malignant potential are the alveolar hyperplasias represented by the classical hyperplastic alveolar nodule and the ductal hyperplasias. The former type of lesion is induced by viral, chemical and hormonal agents; the latter by chemical agents and specific genetic alterations. Individual animal models have been utilized to elucidate the basic biological properties of the lesions and some of the basic molecular alterations. The biological phenotype of the two types of lesions include immortalization and epithelial hyperplasia. The ductal hyperplasias are distinguished from the alveolar hyperplasias by their pattern of epithelial hyperplasia and their extent of aneuploidy. The molecular alterations underlying epithelial hyperplasia are numerous and dependent on the particular animal model. An important issue for future studies is how faithfully any of these models mimic human premalignant progression. A minimal set of criteria is proposed that includes morphological progression, hormone dependence and genetic instability. It is likely that hyperplasias from a specific mouse model will represent a subset of the lesions found in human disease. Analogous hyperplasias from several defined genetic models, adequately characterized at the biological and molecular levels, would provide appropriate models for testing chemopreventive agents.

Entities:  

Mesh:

Year:  2000        PMID: 14973384     DOI: 10.1023/a:1009529928422

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  94 in total

1.  Delayed involution of the mammary epithelium in BALB/c-p53null mice.

Authors:  D J Jerry; C Kuperwasser; S R Downing; J Pinkas; C He; E Dickinson; S Marconi; S P Naber
Journal:  Oncogene       Date:  1998-11-05       Impact factor: 9.867

Review 2.  Protein kinase C isozymes and substrates in mammary carcinogenesis.

Authors:  S C Kiley; J Welsh; C J Narvaez; S Jaken
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-04       Impact factor: 2.673

3.  Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice.

Authors:  Y Matsui; S A Halter; J T Holt; B L Hogan; R J Coffey
Journal:  Cell       Date:  1990-06-15       Impact factor: 41.582

4.  Characterization of Int-5, a locus associated with early events in mammary carcinogenesis.

Authors:  V L Morris; T R Rao; C A Kozak; D A Gray; E C Lee Chan; T J Cornell; C B Taylor; R F Jones; C M McGrath
Journal:  Oncogene Res       Date:  1991

5.  Constitutive expression of a truncated INT3 gene in mouse mammary epithelium impairs differentiation and functional development.

Authors:  G H Smith; D Gallahan; F Diella; C Jhappan; G Merlino; R Callahan
Journal:  Cell Growth Differ       Date:  1995-05

6.  Mammary tumorigenesis in chemical carcinogen-treated mice. IV. Induction of mammary ductal hyperplasias.

Authors:  D Medina; M R Warner
Journal:  J Natl Cancer Inst       Date:  1976-08       Impact factor: 13.506

Review 7.  Genetically engineered mouse models of mammary intraepithelial neoplasia.

Authors:  R D Cardiff; D Moghanaki; R A Jensen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

8.  Role of endocrine, autocrine, and paracrine interactions in the development of mammary hyperplasia in Wnt-1 transgenic mice.

Authors:  T P Lin; R C Guzman; R C Osborn; G Thordarson; S Nandi
Journal:  Cancer Res       Date:  1992-08-15       Impact factor: 12.701

9.  Immortalization phenotype dissociated from the preneoplastic phenotype in mouse mammary epithelial outgrowths in vivo.

Authors:  D Medina; F S Kittrell
Journal:  Carcinogenesis       Date:  1993-01       Impact factor: 4.944

10.  Acceleration of mammary neoplasia in transforming growth factor alpha transgenic mice by 7,12-dimethylbenzanthracene.

Authors:  R J Coffey; K S Meise; Y Matsui; B L Hogan; P J Dempsey; S A Halter
Journal:  Cancer Res       Date:  1994-04-01       Impact factor: 12.701

View more
  18 in total

Review 1.  Murine mammary epithelial stem cells: discovery, function, and current status.

Authors:  Jane E Visvader; Gilbert H Smith
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-02-01       Impact factor: 10.005

Review 2.  Mammary epithelial stem cells: transplantation and self-renewal analysis.

Authors:  Gilbert H Smith; Corinne A Boulanger
Journal:  Cell Prolif       Date:  2003-10       Impact factor: 6.831

3.  Aryl hydrocarbon receptor activation during pregnancy, and in adult nulliparous mice, delays the subsequent development of DMBA-induced mammary tumors.

Authors:  Tao Wang; Heather M Gavin; Volker M Arlt; B Paige Lawrence; Suzanne E Fenton; Daniel Medina; Beth A Vorderstrasse
Journal:  Int J Cancer       Date:  2010-06-02       Impact factor: 7.396

Review 4.  Stem cells and mammary cancer in mice.

Authors:  Gibert H Smith
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

Review 5.  Multistep mouse mammary tumorigenesis through pre-neoplasia to neoplasia and acquisition of metastatic potential.

Authors:  Airo Tsubura; Katsuhiko Yoshizawa; Norihisa Uehara; Takashi Yuri; Yoichiro Matsuoka
Journal:  Med Mol Morphol       Date:  2007-03-29       Impact factor: 2.309

6.  A compendium of the mouse mammary tumor biologist: from the initial observations in the house mouse to the development of genetically engineered mice.

Authors:  Robert D Cardiff; Nicholas Kenney
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-06-01       Impact factor: 10.005

7.  A role for KAI1 in promotion of cell proliferation and mammary gland hyperplasia by the gp78 ubiquitin ligase.

Authors:  Bharat Joshi; Lei Li; Ivan R Nabi
Journal:  J Biol Chem       Date:  2010-01-20       Impact factor: 5.157

Review 8.  Does cancer start in the womb? altered mammary gland development and predisposition to breast cancer due to in utero exposure to endocrine disruptors.

Authors:  Ana M Soto; Cathrin Brisken; Cheryl Schaeberle; Carlos Sonnenschein
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-05-24       Impact factor: 2.673

Review 9.  Common integration sites for MMTV in viral induced mouse mammary tumors.

Authors:  Robert Callahan; Gilbert H Smith
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-08-15       Impact factor: 2.673

Review 10.  Mouse models for radiation-induced cancers.

Authors:  Leena Rivina; Michael J Davoren; Robert H Schiestl
Journal:  Mutagenesis       Date:  2016-05-21       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.